Asenapine: a new approach in the treatment of bipolar disorder

被引：0

作者：

Di Sciascio, G. ^{[1
]}

Calo, S. ^{[2
]}

机构：

[1] Azienda Osped Univ Consorziale Polclin Bari, Unita Operat Psichiat Univ, Bari, Italy

[2] ASL Brindisi, Serv Psichiat Diag & Cura, Brindisi, Italy

来源：

JOURNAL OF PSYCHOPATHOLOGY-GIORNALE DI PSICOPATOLOGIA | 2012年 / 18卷 / 01期

关键词：

Bipolar disorder; Antipsychotics; Asenapine;

D O I：

暂无

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Asenapine is a second-generation antipsychotic that is administered sublingually; the compound received regulatory approval two years ago by FDA for the acute treatment of schizophrenia in adults, and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. In the EMA, at the present, asenapine is approved only for the acute treatment of manic episodes associated with bipolar I disorder in adults. The aim of this review is to summarize published data in both the literature and regulatory documents on efficacy and safety of asenapine for the treatment of bipolar disorder.

引用

页码：92 / 102

页数：11

共 43 条

[11]

Gerrits M, 2008, CLIN PHARMACOL THER, V83, pS29

[12] Electrophysiological characterization of the effects of asenapine at 5-HT1A, 5-HT2A, α2-adrenergic and D2 receptors in the rat brain [J].

Ghanbari, Ramez ;

El Mansari, Mostafa ;

Shahid, Mohammed ;

Blier, Pierre .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (03) :177-187

[13] The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania [J].

Grunze, Heinz ;

Vieta, Eduard ;

Goodwin, Guy M. ;

Bowden, Charles ;

Licht, Rasmus W. ;

Moeller, Hans-Juergen ;

Kasper, Siegfried .

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2009, 10 (02) :85-116

[14] Functional, molecular and pharmacological advances in 5-HT7 receptor research [J].

Hedlund, PB ;

Sutcliffe, JG .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (09) :481-486

[15] Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus [J].

Huang, Mei ;

Li, Zhu ;

Dai, Jin ;

Shahid, Mohammed ;

Wong, Erik H. F. ;

Meltzer, Herbert Y. .

NEUROPSYCHOPHARMACOLOGY, 2008, 33 (12) :2934-2945

[16]

HULSKOTTE E, 2009, 162 ANN M AM PSYCH A

[17] Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets - Role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia [J].

Johnson, DE ;

Yamazaki, H ;

Ward, KM ;

Schmidt, AW ;

Lebel, WS ;

Treadway, JL ;

Gibbs, EM ;

Zawalich, WS ;

Rollema, H .

DIABETES, 2005, 54 (05) :1552-1558

[18] Asenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study [J].

McIntyre, Roger S. ;

Cohen, Miriam ;

Zhao, Jun ;

Alphs, Larry ;

Macek, Thomas A. ;

Panagides, John .

JOURNAL OF AFFECTIVE DISORDERS, 2010, 126 (03) :358-365

[19] Pharmacology and efficacy of asenapine for manic and mixed states in adults with bipolar disorder [J].

McIntyre, Roger S. .

EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (05) :645-649

[20] Asenapine in the treatment of acute mania in bipolar I disorder: A randomized, double-blind, placebo-controlled trial [J].

McIntyre, Roger S. ;

Cohen, Miriam ;

Zhao, Jun ;

Alphs, Larry ;

Macek, Thomas A. ;

Panagides, John .

JOURNAL OF AFFECTIVE DISORDERS, 2010, 122 (1-2) :27-38

← 1 2 3 4 5 →